A systematic review of clinical and preclinical studies found that psilocybin can modulate the HPA axis, which regulates the body’s stress response. Across multiple trials in people with major depressive disorder, psilocybin treatment was linked to balanced cortisol and ACTH levels and improved regulation of stress-related pathways. This modulation may be one way psilocybin supports mood stabilization and reduces depressive symptoms.